Right now TERP is number 88 for the largest percentage gain

Ovarian Cancer Treatment Sees a New Challenger Alright, folks, Eli Lilly (NYSE:LLY) is stepping up with their latest findings in ovarian cancer treatment, and it's got plenty of people in a buzz. They've dropped new data for their investigational drug, Sofetabart mipitecan, or 'Sofe-M' for short, which targets this unrelenting disease with a punch that’s hard to ignore....

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Class Action Puts Darden Restaurants in Legal Hot Seat Darden Restaurants, Inc. is staring down the barrel of a lawsuit that's as fiery as a grill on a Saturday night rush. The legal cavalry from Blumenthal Nordrehaug Bhowmik De Blouw LLP has stormed in with a class action complaint, aiming dead center at Darden for allegedly breaching the California Labor Code. In plain...

Ah, the ticking clock in the world of stock investments, where a nifty little thing called a class action lawsuit can flip your investment on its head. Right now, AST SpaceMobile (NASDAQ: ASTS) investors are staring down the barrel of one such lawsuit. With the November 13, 2026, deadline looming, it's time to sort the facts from the muck. Pins and Needles for ASTS...

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Wines Jockeying for New York’s Coveted Lists Alright, picture a stage set up in New York City like an arena. But instead of gladiators, you've got master sommeliers on one side and Italian wine producers on the other, each armed with their own arguments. They're locked in a battle over what it really takes to get a bottle imbedded on a New York City's prestigious wine...

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

The International Energy Agency (IEA) flagged back in 2024 that the world was stepping into a new chapter in energy markets, with whispers of affordable prices on the horizon. The game-changer? A surge in electricity use was creating global surpluses of oil and gas resources, setting the stage for a whole new dynamic. Global Energy Trends: Demand Shifts or Supply Surges?...

BayCare Announces Exciting Leadership Change In a significant move towards enhancing its operational effectiveness, BayCare has appointed Kristen A. Vogl, PT, DPT, MBA, as the new vice president of service lines. With over two decades of experience in various healthcare settings, Vogl is set to elevate BayCare's mission of providing excellent care and improving patient...

Optimistic Outlook for Investor Favorites In a recent update, leading Wall Street analysts have revised their ratings, signaling an optimistic trend for several prominent companies. Analysts have made notable upgrades, reflecting growing confidence in these stocks' future performance. Let's explore five significant upgrades and what they mean for investors. Ecolab Inc...

Key Earnings Reports Coming Up As we move deeper into earnings season, several significant companies are set to unveil their financial results. Among these, State Street (NYSE: STT), a major player in the financial services industry, stands out this Friday, accompanied by oil giant Schlumberger and the well-known regional bank, Regions Financial (NYSE: RF). These...

Kenneth Fisher Joins APA Corporation's Board of Directors APA Corporation (NASDAQ: APA) is excited to announce a significant leadership change with the appointment of Kenneth M. Fisher to its board of directors. A Warm Welcome to Ken Fisher Lamar McKay, APA’s non-executive board chair, expressed enthusiasm about Fisher’s addition to the board. He stated, “We are...